Isoniazid preventive therapy in medium-incidence settings: the price is right.
Publication
, Journal Article
Stout, JE; Andrews, JR
Published in: Int J Tuberc Lung Dis
December 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Int J Tuberc Lung Dis
DOI
EISSN
1815-7920
Publication Date
December 2014
Volume
18
Issue
12
Start / End Page
1388
Location
France
Related Subject Headings
- Microbiology
- Mass Screening
- Latent Tuberculosis
- Isoniazid
- Humans
- HIV Infections
- Drug Costs
- Coinfection
- Antitubercular Agents
- 4202 Epidemiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Stout, J. E., & Andrews, J. R. (2014). Isoniazid preventive therapy in medium-incidence settings: the price is right. Int J Tuberc Lung Dis, 18(12), 1388. https://doi.org/10.5588/ijtld.14.0760
Stout, Jason E., and Jason R. Andrews. “Isoniazid preventive therapy in medium-incidence settings: the price is right.” Int J Tuberc Lung Dis 18, no. 12 (December 2014): 1388. https://doi.org/10.5588/ijtld.14.0760.
Stout JE, Andrews JR. Isoniazid preventive therapy in medium-incidence settings: the price is right. Int J Tuberc Lung Dis. 2014 Dec;18(12):1388.
Stout, Jason E., and Jason R. Andrews. “Isoniazid preventive therapy in medium-incidence settings: the price is right.” Int J Tuberc Lung Dis, vol. 18, no. 12, Dec. 2014, p. 1388. Pubmed, doi:10.5588/ijtld.14.0760.
Stout JE, Andrews JR. Isoniazid preventive therapy in medium-incidence settings: the price is right. Int J Tuberc Lung Dis. 2014 Dec;18(12):1388.
Published In
Int J Tuberc Lung Dis
DOI
EISSN
1815-7920
Publication Date
December 2014
Volume
18
Issue
12
Start / End Page
1388
Location
France
Related Subject Headings
- Microbiology
- Mass Screening
- Latent Tuberculosis
- Isoniazid
- Humans
- HIV Infections
- Drug Costs
- Coinfection
- Antitubercular Agents
- 4202 Epidemiology